Hence, the concentration or activity of serum ACE2 has been thoroughly measured as a vascular biomarker in COVID-19 [18] with, however, controversial results about its level [19,20,21,22,23,24,25,26,27]. This evidence concerns the gene ACE2 and COVID-19.